APY Apergy Corporation

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Bryant Deric D.	2. Issuer Name and Ticker or Trading Symbol ChampionX Corp [ CHX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) See remarks
(Last)          (First)          (Middle) C/O CHAMPIONX CORP, 2445 TECHNOLOGY, FOREST BLVD, BLDG 4, 12TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 6/3/2020
(Street) THE WOODLANDS, TX 77381 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	6/3/2020		A		578396	A	$0	578396	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.65	6/3/2020		A		52561		6/3/2020	12/1/2021	Common Stock	52561.0	$0	52561	D
Stock Option (Right to Buy)	$3.41	6/3/2020		A		48356		6/3/2020	12/5/2022	Common Stock	48356.0	$0	48356	D
Stock Option (Right to Buy)	$4.92	6/3/2020		A		36162		6/3/2020	12/4/2023	Common Stock	36162.0	$0	36162	D
Stock Option (Right to Buy)	$5.13	6/3/2020		A		49303		6/3/2020	12/3/2024	Common Stock	49303.0	$0	49303	D
Stock Option (Right to Buy)	$5.67	6/3/2020		A		52540		6/3/2020	12/2/2025	Common Stock	52540.0	$0	52540	D
Stock Option (Right to Buy)	$5.6	6/3/2020		A		152408		6/3/2020	12/7/2026	Common Stock	152408.0	$0	152408	D
Stock Option (Right to Buy)	$6.53	6/3/2020		A		290541		6/3/2020 (1)	12/6/2027	Common Stock	290541.0	$0	290541	D
Stock Option (Right to Buy)	$7.54	6/3/2020		A		228287		6/3/2020 (2)	12/4/2028	Common Stock	228287.0	$0	228287	D

Explanation of Responses:
(1)	Includes 193,680 shares exercisable on 6/3/2020, and 96,861 shares that become exercisable 12/6/2020.
(2)	Includes 76,089 shares exercisable on 6/3/2020, with the remaining 152,198 shares becoming exercisable in two equal annual installments beginning 12/4/2020.

Remarks: Chief Operating Officer and President, Chemical Technologies

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Bryant Deric D. C/O CHAMPIONX CORP, 2445 TECHNOLOGY FOREST BLVD, BLDG 4, 12TH FLOOR THE WOODLANDS, TX 77381			See remarks

Signatures
/s/ Julia Wright, as attorney-in-fact		6/5/2020
**Signature of Reporting Person		Date